Log In
Print
BCIQ
Print
Print this Print this
 

3K3A-APC

  Manage Alerts
Collapse Summary General Information
Company Socratech LLC
DescriptionRecombinant variant of human activated protein C (APC)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard IndicationStroke
Indication DetailsTreat acute ischemic stroke
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today